Hepatitis G virus or GBV-C: A natural anti-HIV interfering virus

Viruses: Essential Agents of Life

Volumn 9789400748996, Issue , 2012, Pages 363-388

  Bagasra, Omar ^a   Sheraz, Muhammad ^a   Pace, Donald Gene ^a  

^a CLAFLIN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887536115     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-4899-6_18     Document Type: Chapter

References (77)

1. Abu Odeh RO (2011) Detection and genotyping of GB virus-C in dromedary camels in the United Arab Emirates. Vet Microbiol 147:226-230
2. Bagasra O (1999) HIV and molecular immunity: prospect for AIDS vaccine. Eaton Publishing, Natic
3. Bagasra O (2006) A unified concept of HIV-1 Latency. Expert Opin Biol Ther 6:1135-1149
4. Bagasra O, Pace DG (2010) Back to the soil: retroviruses and transposons. In: Biocommunication of soil-bacteria and viruses. Springer, Heidelberg/Dordrecht/London/New York, pp 161-188
5. Bagasra O, Pace DG (2012) Immunology and the quest for an HIV vaccine: A new perspective (Chapter 1). AuthorHouse, Bloomington, pp 1-45
6. Bagasra O, Prilliman KP (2004) RNA Interference: The molecular immune system. J Mol Histol 35:545-553
7. Bagasra O, Sheraz M (2011) Role of GBV-C specific miRNAs in HIV-1 inhibition. At the 111th ASM annual conference, May 21-25 New Orleans, LA, Oral Presentation, Session #90
8. Bagasra O, Stir AE, Pirisi-Creek L, Creek KE, Bagasra O, Pace G, Lee JS (2006) Role of miRNAs in regulation of lentiviral latency and persistence. App Immunochem Mol Morphol 14:276-290
9. Bagasra O, Bagasra AU, Sheraz M, Pace DG (2012) Potential utility of GBV-C as a preventive vaccine for HIV-1. Expert Rev Vaccin 11(3):335-347
10. Berzsenyi MD, Woollard DJ, McLean CA, Preiss S, Perreau VM, Beard MR, Scott Bowden D, Cowie BC, Li S, Mijch AM, Roberts SK (2011) Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. J Hepatol 55(3):536-544
11. Birk M, Lindback S, Lidman C (2002) No influence of Gb virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 16:2482-2485
12. Björkman P, Widell A (2008) HIV and Gb virus C infections seen from the perspective of the vertically coexposed infant. J Infect Dis 197(10):1358-1360
13. Bjorkman P, Naucler A, Winqvist N, Mushahwar I, Widell A (2001) A casecontrol study of the transmission routes for Gb virus C/hepatitis G virus in Swedish blood donors lacking markers for hepatitis C virus infection. Vox Sang 81:148-153
14. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A (2004) GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 18:877-886
15. Bosinger SE, Sodora DL, Silvestri G (2011) Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr Opin HIV AIDS 6(5):411-418
16. Campos AF, Tengan FM, Silva SA, Levi JE (2011) Influence of hepatitis G virus (Gb virus C) on the prognosis of HIV-infected women. Int J STD AIDS 22(4):209-213
17. Ernst D, Pischke S, Greer M, Wedemeyer H, Stoll M (2011) No increased incidence for GB-virus C infection in a cohort of HIV-positive lymphoma patients. Int J Cancer 128(12):3013
18. Fenizia C, Keele BF, Nichols D, Cornara S, Binello N, Vaccari M, Pegu P, Robert-Guroff M, Ma ZM, Miller CJ, Venzon D, Hirsch V, Franchini G (2011) TRIM5 a does not affect Simian Immunodeficiency Virus SIVmac251 replication in vaccinated or unvaccinated Indian Rhesus Macaques following intrarectal challenge exposure. J Virol 85(23):12399-12409
19. George SL, Varmaz D, Stapleton JT (2006) GB virus C replicates in primary T and B lymphocytes. J Infect Dis 193:451-454
20. Gómara MJ, Fernández L, Pérez T, Ercilla G, Haro I (2010) Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection. Anal Biochem 396(1):51-58
21. Gómara MJ, Fernández L, Pérez T, Tenckhoff S, Casanovas A, Tillmann HL, Haro I (2011) Diagnostic value of anti-GBV-C antibodies in HIV-infected patients. Chem Biol Drug Des 78(2):277-282
22. Hakim ST, Alsayari M, McLean DC, Saleem S, Addanki KC, Aggarwal M, Mahalingam K, Bagasra O (2008) A large number of the primate MicroRNAs target lentiviruses, RE and endogenous retroviruses. BBRC 369:357-362
23. Haro I, Gómara MJ, Galatola R, Domènech O, Prat J, Girona V, Busquets MA (2011) Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity. Biochim Biophys Acta 1808(6):1567-1573
24. Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, Hunt J, Jou C, Solomon N, Schmidt RE, Manns MP (1998) GB virus C/hepatitis G virus infection: A favorable prognostic factor in human immunodeficiency virus infected patients? J Infect Dis 177:1723-1726
25. Herrera E, Gómara MJ, Mazzini S, Ragg E, Haro I (2009) Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide. J Phys Chem B 113(20):7383-7391
26. Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I (2010) Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection. J Med Chem 53(16):6054-6063
27. Horvilleur E, Wilson LA, Willis AE (2010) Translation deregulation in B-cell lymphomas. Biochem Soc Trans 38(6):1593-1597
28. Houzet L, Yeung ML, de Lame V, Desai D, Smith SM, Jeang KT (2008) MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 5:118
29. Jopling C (2012) Liver-specific microRNA-122: biogenesis and function. RNA Biol 9(2):137-142
30. Kaiser T, Tillmann HL (2005) Gb virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? AIDS Rev 7(1):3-12
31. Kanak MA, Alseiari MA, Addanki KC, Aggarwal M, Noorali S, Kalsum A, Mahalingam K, Panasik N, Pace DG, Bagasra O (2010) Triplex Forming microRNAs Form Stable Complexes with HIV-1 provirus and Inhibit Its Replication. Appl Immunohistochem Mol Morphol 18(6):532-545
32. Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H (2011) Peptides derived from a distinct region of Gb virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition. J Virol 85(14):7037-7047
33. Korber BT, Letvin NL, Haynes BF (2009) (2010) T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces. J Virol 83(17):8300-8314
34. Kotani A, Harnprasopwat R, Toyoshima T, Kawamata T, Tojo A (2010) miRNAs in normal and malignant B cells. Int J Hematol 92(2):255-261
35. Krajden M, Yu A, Braybrook H, Lai AS, Mak A, Chow R, Cook D, Tellier R, Petric M, Gascoyne RD, Connors JM, Brooks-Wilson AR, Gallagher RP, Spinelli JJ (2010) GBV-C/ hepatitis G virus infection and non-Hodgkin lymphoma: A case control study. Int J Cancer 126(12):2885-2892
36. Kwong PD (2005) Human immunodeficiency virus: refolding the envelope. Nature 433(7028): 815-816
37. Lama J (2003) The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr HIV Res 1(2):167-184
38. Lauring AS, Jones JO, Andino R (2010) Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol 28(6):573-579
39. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1996) Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 48:60-67
40. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saïb A, Voinnet O (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308(5721):557-560
41. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M, Mariotti M (1999) Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 179:783-789
42. Luciw PA, Shaw KE, Unger RE, Planelles V, Stout MW, Lackner JE, Pratt-Lowe E, Leung NJ, Banapour B, Marthas ML (1992) Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res Hum Retroviruses 8(3):395-402
43. Medzhitov R, Littman D (2008) HIV immunology needs a new direction. Nature 455:591
44. Moenkemeyer M, Schmidt RE, Wedemeyer H, Tillmann HL, Heiken H (2008) GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients. J Med Virol 80(11):1933-1940
45. Mohr EL, Stapleton JT (2009) GB virus type C interactions with HIV: The role of envelope glycoproteins. J Viral Hepat 16(11):757-768
46. Mohr EL, Xiang J, McLinden JH, Kaufman TM, Chang Q, Montefiori DC, Klinzman D, Stapleton JT (2010) GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J Immunol 185(7): 4496-4505
47. Mohr EL, Murthy KK, McLinden JH, Xiang J, Stapleton JT (2011) The natural history of nonhuman Gb Virus C (GBV-Ccpz) in captive chimpanzees. J Gen Virol 92:91-100
48. Morita K, Taketomi A, Shirabe K, Umeda K, Kayashima H, Ninomiya M, Uchiyama H, Soejima Y, Maehara Y (2010) Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int. doi: 10.1111/j.1478-3231.2010.02433
49. Muerhoff AS, Smith DB, Leary TP, Erker JC, Desai Mushahwar IK (1997) Identification of GB virus C variants by phylogenetic analysis of 5'-untranslated and coding region sequences. J Virol 71:6501-6508
50. Naito H, Abe K (2001) Genotyping system of GBV-C/HGV type 1 to type 4 by the polymerase chain reaction using typespecific primers and geographical distribution of viral genotypes. J Virol Methods 91:3-9
51. Nicolosi GS, Lopez-Guillermo A, Falcone U, Conconi A, Christinat A, Rodriguez-Abreu D, Grisanti S, Lobetti-Bodoni C, Piffaretti JC, Johnson PW, Mombelli G, Cerny A, Montserrat E, Cavalli F, Zucca E (2011) Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: A case-control study of the International Extranodal Lymphoma Study Group. Hematol Oncol Nov 21
52. O'huigin C, Kulkarni S, Xu Y, Deng Z, Kidd J, Kidd K, Gao X, Carrington M (2011) The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. Am J Hum Genet 89(3):424-431
53. Parreira R, Branco C, Piedade J, Esteves A (2012) Gb virus C (GBV-C) evolutionary patterns revealed by analyses of reference genomes, E2 and NS5B sequences amplified from viral strains circulating in the Lisbon area (Portugal). Infect Genet Evol 12(1):86-93
54. Pfeffer S, Baumert TF (2010) Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection. Gastroenterol Clin Biol 34(8-9):431-435
55. Qiu L, Fan H, Jin W, Zhao B, Wang Y, Ju Y, Chen L, Chen Y, Duan Z, Meng S (2010) miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochem Biophys Res Commun 398(4):771-777
56. Reshetnyak VI, Karlovich TI, Ilchenko LU (2008) Hepatitis G virus. World J Gastroenterol 14(30):4725-4734
57. Sánchez-Martín MJ, Busquets MA, Girona V, Haro I, Alsina MA, Pujol M (2011a) Effect of E1(64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models. Biochim Biophys Acta 1808(9):2178-2188
58. Sánchez-Martín MJ, Urbán P, Pujol M, Haro I, Alsina MA, Busquets MA (2011b) Biophysical Investigations of GBV-C E1 Peptides as Potential Inhibitors of HIV-1 Fusion Peptide. Chemphyschem 12(15):2816-2822
59. Sathar MA, York DF, Gouws E, Coutsoudis A, Coovadia HM (2004) GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZulu Natal, South Africa. Clin Infect Dis 38:405-409
60. Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung RT, Rockstroh JK, Spengler U (2010) Gb virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir Ther 15(5):745-752
61. Shankar EM, Balakrishnan P, Vignesh R, Velu V, Jayakumar P, Solomon S (2011) Current views on the pathophysiology of Gb virus C coinfection with HIV-1 infection. Curr Infect Dis Rep 13(1):47-52
62. Smith DB, Cuceanu N, Davidson F, Jarvis LM, Mokili JL, Hamid S, Ludlam CA, Simmonds P (1997) Discrimination of hepatitis G virus/GBVC geographical variants by analysis of the 5'non-coding region. J Gen Virol 78:1533-1542
63. Stapleton JT (2003) Gb virus type C/Hepatitis G virus. Semin Liver Dis 23:137-148
64. Stapleton JT, Chaloner K (2010) Gb virus C infection and non-Hodgkin lymphoma: important to know but the jury is out. Int J Cancer 126(12):2759-2761
65. Stapleton JT, Williams CF, Xiang J (2004) Gb virus type C: A beneficial infection? J Clin Microbiol 42:3915-3919
66. Suresh P, Wanchu A, Bhatnagar A, Sachdeva RK, Sharma M (2007) Spontaneous and antigeninduced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India. AIDS Res Hum Retroviruses 23(2):261-268
67. The International HIV, Study C (2010) The major genetic determinants of HIV-1 control affect HLA Class I peptide presentation. Science 330:1551
68. Tillmann HL, Manns MP (2001) Gb virus-C infection in patients infected with the human immunodeficiency virus. Antiviral Res 52:83-90
69. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP (2001) Infection with Gb virus C and reduced mortality among HIV-infected patients. N Engl J Med 345:715-724
70. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H (1998) Effect of Gb virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 17:209-213
71. Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, JMA Lange R, Coutinho A, Schuitemaker H (2005) Gb virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 191:678-685
72. Walker BD, Goulder PJ (2000) AIDS. Escape from the immune system. Nature 407:313-314
73. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT (2001) Effect of coinfection with Gb virus C on survival among patients with HIV infection. N Engl J Med 345:707-714
74. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT (2004) Inhibition of HIV-1 replication by Gb virus C infection through increases in RANTES, MIP-1a, MIP-1b, and SDF-1. Lancet 363:2040-2046
75. Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT (2006) Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: A meta-analysis. HIV Med 7:173-180
76. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H (2010) Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res 88(2):169-175
77. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445(7129):732-737